$46.79
(1.15x)
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Roivant Sciences Ltd. vs Genmab A/S: key figures
 Roivant Sciences Ltd. ROIV |
 Genmab A/S GMAB |
|
|---|---|---|
| Rank | #821 | #716 |
| Price | $40.67 | $549.56 |
| Market cap | $29.38B | $33.79B |
| Shares Outstanding | 722.32M | 61.49M |
| Change (1 day) | +4.60% | +4.48% |
| Change (1 year) | +94.59% | +84.59% |
The other way round: GMAB with the market cap of ROIV
$477.72 (0.87x)
If Genmab A/S (GMAB) had the market cap of Roivant Sciences Ltd. (ROIV), one GMAB would cost $477.72, 13.07% less than today's price of $549.56.
Price of GMAB with the Market Cap of ROIVPrice of ROIV with the Market Cap of GMAB: the last 12 months
The price of one ROIV if Roivant Sciences Ltd. had the market cap of Genmab A/S, at the end of each month. Highest: $49.72 (Oct 2026). Lowest: $23.65 (May 2026).
- $28.64 Nov 2025
- $28.84 Dec 2025
- $29.02 Jan 2026
- $25.95 Feb 2026
- $24.05 Mar 2026
- $23.73 Apr 2026
- $23.65 May 2026
- $24.92 Jun 2026
- $25.02 Jul 2026
- $49.72 Oct 2026
- $46.79 Nov 2026
Questions about Roivant Sciences Ltd. and Genmab A/S
What would the price of Roivant Sciences Ltd. be with the market cap of Genmab A/S?
If Roivant Sciences Ltd. (ROIV) had the market cap of Genmab A/S (GMAB), one ROIV would cost $46.79, 1.15 times today's price of $40.67.
How much bigger is Genmab A/S than Roivant Sciences Ltd.?
The market cap of Genmab A/S ($33.79B) is 1.15 times that of Roivant Sciences Ltd. ($29.38B). In Nov 2025 the gap was 1.38 times.
What would the price of Genmab A/S be with the market cap of Roivant Sciences Ltd.?
If Genmab A/S (GMAB) had the market cap of Roivant Sciences Ltd. (ROIV), one GMAB would cost $477.72, 13.07% less than today's price of $549.56.
How is this price calculated?
The market cap of Genmab A/S ($33.79B) is divided by the number of ROIV in circulation (722.32M). Market cap is the price multiplied by the number of coins or shares in circulation.
